| Authors: |
Mariottini A; Department of Neurofarba, University of Florence, Florence, Italy; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy., Stack EH; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, 20892 USA., Nair G; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, 20892 USA., Nozzoli C; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Wu T; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, 20892 USA., Marchi L; Department of Neurofarba, University of Florence, Florence, Italy., Boncompagni R; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Repice AM; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy., Fainardi E; Neuroradiology Unit, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy; Neuroradiology Unit, Department of Radiology, Careggi University Hospital, Florence, Italy., Pasquale FD; Diagnostic Imaging Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Carlesi E; Neuroradiology Unit, Department of Radiology, Careggi University Hospital, Florence, Italy., Saccardi R; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Jacobson S; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, 20892 USA., Massacesi L; Department of Neurofarba, University of Florence, Florence, Italy; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy. Electronic address: massacesi@unifi.it. |
